HOME >> MEDICINE >> NEWS
Trial reveals safer and simpler approach to treating children with cystic fibrosis

Treating chest infections in young cystic fibrosis patients with an antibiotic once instead of three times daily is as effective and less toxic, conclude the results of a randomised trial published in this week's issue of THE LANCET.

Aminoglycoside antibiotics are widely used for the management of patients who have cystic fibrosis and chronic chest infection with a bacterium called Pseudomonas aerginosa. Currently patients are given aminoglycosides three times daily. The drugs can cause damage to kidney function and hearing loss.

Alan Smyth (University of Nottingham, UK) and colleagues recruited 219 cystic fibrosis patients (125 children and 94 adults) between 1999 and 2003 in the UK. The patients were randomly assigned to receive an aminoglycoside called tobramycin intravenously once or three times daily for 14 days. The researchers measured changes in lung function and found that the two treatments had a similar effect. However in children, the once daily treatment caused fewer kidney related side effects.

Dr Alan Smyth comments: "Our results are likely to affect aminoglycoside prescription in cystic fibrosis in clinical practice. Once daily treatment may be preferred by patients receiving intravenous antibiotics because of its convenience. Antipseudomonal antibiotics are usually given as combinations of two or more drugs in cystic fibrosis because of concerns of emerging antibiotic resistance. Most other antipseudomonal antibiotics need to be given three times daily and so further development of other once daily antibiotics would be useful."

In an accompanying commentary Heather VandenBussche (Bronson Methodist Hospital, Michigan, USA) and Michael Klepser (Ferris State University College of Pharmacy, Michigan, USA) write that several unanswered questions persist about once daily aminoglycoside dosing in cystic fibrosis patients.

Dr VandenBussche concludes: " Smyth and colleagues' report provides some useful insights into
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
10-Feb-2005


Page: 1 2

Related medicine news :

1. Trials launched to test treatment of cognitive dysfunction in schizophrenia
2. Randomisation phase of the DIRECT programme (DIabetic REtinopathy Candesartan Trials) completed
3. Trials on hormone therapy and hypertension treatment change practice, medication usage of patients
4. Trial results have dramatically reduced HRT use
5. Release of results of Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
6. Trial opens new possibilities for improving survival with a novel heart attack drug
7. Clinical Trials Litigation: Legal & Ethical Issues in Human Subjects Research
8. National Lung Screening Trial
9. New awards, expanded focus for Pediatric AIDS Clinical Trials Group
10. AAPS Workshop to Examine Chemistry and Manufacturing Controls Trials, Emerging Products
11. Abgenix Reports Positive Survival Data From A Phase II Trial Of ABX-CBL In Graft Versus Host Disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/13/2019)... ... 2019 , ... cbdMD, Inc., a nationally recognized consumer cannabidiol ... Brightfield Group, a leading cannabis research firm. In their recent mid-year 2019 Market ... in two categories, Topicals and Skincare/Beauty. , "There is a massive shakeup in ...
(Date:7/11/2019)... ... July 11, 2019 , ... ... 1 the expansion of its territory through the acquisition of another Houston-area distributor. ... region to include three facilities located in LaPorte, Nederland and Houston. , ...
(Date:7/10/2019)... ... ... HMP, a leader in healthcare events and education, today announced the Community ... place October 11-13, 2019 in Boston. , Launched in 2016, the Congress is the ... clinical pathways as a decision support tool and their increasing influence on patient care. ...
(Date:7/9/2019)... (PRWEB) , ... July 09, 2019 , ... Human cytomegalovirus ... to Xiaoping Zhu, professor and chair in Veterinary Medicine at UMD, half of the ... dormant in your body for the rest of your life and can flare up ...
(Date:7/9/2019)... ... July 09, 2019 , ... Smile ... support services to more than 400 affiliated offices across 17 states, is pleased ... , Smile Brands will provide full-service administrative support to the practice, including; purchasing, ...
Breaking Medicine News(10 mins):
(Date:7/11/2019)... Tenn. (PRWEB) , ... July 11, 2019 , ... ... announced the addition of Jaylee Hilliard, MSN, RN, NEA-BC, as a clinical advisor. ... Health. She joins the AngelEye Health team with more than a decade of ...
(Date:7/11/2019)... PHILADELPHIA (PRWEB) , ... July 11, 2019 , ... ... from hemp, has recently created products in line with TSA guidelines for domestic ... In May 2019, the TSA changed its guidelines to allow some ...
(Date:7/11/2019)... ... July 11, 2019 , ... Nobility RCM, ... partnership with Palmer College of Chiropractic, the first and largest chiropractic college in ... specially selected to handle its billing and revenue cycle for the institution’s clinical ...
Breaking Medicine Technology:
Cached News: